tallózása szerző szerint "Engel FB"

1-7 / 7

Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischemic heart?

Perrino C; Barabasi AL; Condorelli G; Davidson SM; De Windt L; Dimmeler S; Engel FB; Hausenloy DJ; Hill JA; Van Laake LW; Lecour S; Leor J; Madonna R; Mayr M; Prunier F; Sluijter JP; Schulz R; Thum T; Ytrehus K; Ferdinandy, Péter (2017)

Despite advances in myocardial reperfusion therapies, acute myocardial ischemia/reperfusion injury and consequent ischemic heart failure represent the number one cause of morbidity and mortality in industrialized societies. ...
ESC Working Group Cellular Biology of the Heart: Position Paper: Improving the pre-clinical assessment of novel cardioprotective therapies

Lecour S; Botker HE; Condorelli G; Davidson SM; Garcia-Dorado D; Engel FB; Ferdinandy, Péter; Heusch G; Madonna R; Ovize M; Ruiz-Meana M; Schulz R; Sluijter JP; Van Laake LW; Yellon DM; Hausenloy DJ (2014)

Ischemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischemia-reperfusion injury, ...
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology

Sluijter JPG; Davidson SM; Boulanger CM; Buzás, Edit Irén; de Kleijn DPV; Engel FB; Giricz, Zoltán; Hausenloy DJ; Kishore R; Lecour S; Leor J; Madonna R; Perrino C; Prunier F; Sahoo S; Schiffelers RM; Schulz R; Van Laake LW; Ytrehus K; Ferdinandy, Péter (2018)

Extracellular vesicles (EVs)-particularly exosomes and microvesicles (MVs)-are attracting considerable interest in the cardiovascular field as the wide range of their functions is recognized. These capabilities include ...
From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"

Cabrera-Fuentes HA; Aragones J; Bernhagen J; Boening A; Boisvert WA; Botker HE; Bulluck H; Cook S; Di Lisa F; Engel FB; Engelmann B; Ferrazzi F; Ferdinandy, Péter; Fong A; Fleming I; Gnaiger E; Hernandez-Resendiz S; Kalkhoran SB; Kim MH; Lecour S; Liehn EA; Marber MS; Mayr M; Miura T; Ong SB; Peter K; Sedding D; Singh MK; Suleiman MS; Schnittler HJ; Schulz R; Shim W; Tello D; Vogel CW; Walker M; Li QO; Yellon DM; Hausenloy DJ; Preissner KT (2016)

In this meeting report, particularly addressing the topic of protection of the cardiovascular system from ischemia/reperfusion injury, highlights are presented that relate to conditioning strategies of the heart with ...
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart

Hausenloy DJ; Garcia-Dorado D; Erik Botker H; Davidson SM; Downey J; Engel FB; Jennings R; Lecour S; Leor J; Madonna R; Ovize M; Perrino C; Prunier F; Schulz R; Sluijter JP; Van Laake LW; Vinten-Johansen J; Yellon DM; Ytrehus K; Heusch G; Ferdinandy, Péter (2017)

Ischaemic heart disease and the heart failure that often results, remain the leading causes of death and disability in Europe and worldwide. As such, in order to prevent heart failure and improve clinical outcomes in ...
Novel Therapeutic Strategies for Cardioprotection

Sluijter JP; Condorelli G; Davidson SM; Engel FB; Ferdinandy, Péter; Hausenloy DJ; Lecour S; Madonna R; Ovize M; Ruiz-Meana M; Schulz R; Van Laake LW; Nucleus of the European Society of Cardiology Working Group Cellular Biology of the Heart (2014)

The morbidity and mortality from ischemic heart disease (IHD) remain significant worldwide. The treatment for acute myocardial infarction has improved over the past decades, including early reperfusion of occluded coronary ...
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure

Madonna R; Van Laake LW; Davidson SM; Engel FB; Hausenloy DJ; Lecour S; Leor J; Perrino C; Schulz R; Ytrehus K; Landmesser U; Mummery CL; Janssens S; Willerson J; Eschenhagen T; Ferdinandy, Péter; Sluijter JP (2016)

Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic heart disease (IHD) and heart failure (HF) remain significant in Europe and worldwide. Patients with IHD may benefit from ...

1-7 / 7

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Engel FB"

DSpace/Manakin Repository

tallózása szerző szerint "Engel FB"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem